Additionally, positive findings from trials like ADRIATIC (NCT03703297) and IMforte (NCT05091567) are further shaping ...

Key advances taking place across the field of cancer research will be explored at this popular online event. We will bring together a broad cross-section of experts to share their work in areas such ...

Learn how personalised treatments are providing new hope with tailored therapies offering better outcomes for patients ...

Arovella Therapeutics Limited (AU:ALA) has released an update. Arovella Therapeutics Limited, listed on ASX as ALA, is making significant ...

this comprehensive analysis represents a significant advancement in the understanding of these unique immune cells and their ...